Jeanette presents E-poster at IPVC 2021
The virtual 34th International Papillomavirus Conference took place last week, from November 15-19. The conference’s theme this year was: ‘Research and education for HPV elimination’.
...
2A Pharma
2A Pharma is a clinical stage Swedish/Danish biopharmaceutical company focused on discovering, developing and commercialising novel, cost effective prophylactic and therapeutic vaccines based on our patented AAVLP platform.
Our Mission
To develop novel, cost effective prophylactic and therapeutic vaccines based on the AAVLP platform for the benefit of both future vaccine recipients and our investors.
LEARN MORE
Recent news
2A Pharma is a clinical stage Swedish/Danish biopharmaceutical company focused on discovering, developing and commercialising novel, cost effective prophylactic and therapeutic vaccines based on our patented AAVLP Platform.
Clinical trials explained
On November 4, Jeanette Prangsgaard held a presentation at the ‘Clinical Trials’ even, organised by Synapse – Life Science Connect Aalborg.
...
Dosing completed
All volunteers have now received three doses of 2AP01 (AAVLP-HPV), our very broad spectrum HPV vaccine formulated without adjuvant. The vaccine is well tolerated and no serious adverse events (SAEs)have been observed to date.
...
